Abstract
Cancer remains a critical global health challenge, necessitating the development of highly effective, low-toxicity therapeutic interventions. Photothermal therapy (PTT) has emerged as a promising noninvasive approach, utilizing nanomaterials to convert light energy into localized heat to eradicate tumor cells. Gold nanorods (GNRs) are particularly noteworthy due to their tunable optical properties and versatility in biological applications. This review examines recent advancements in GNR synthesis and surface functionalization, focusing on strategies to reduce toxicity, enhance tumor targeting, and improve pharmacokinetics. By integrating GNRs with drug delivery and immunotherapy, researchers are paving the way for more precise and synergistic cancer treatments.
Introduction: The Promise of Photothermal Therapy
Traditional cancer treatments, such as chemotherapy and radiation, often act as "blunt instruments," causing significant collateral damage to healthy tissues. Photothermal therapy (PTT) offers a more surgical alternative: light-sensitive nanomaterials are delivered to the tumor site and activated by a laser to generate heat. Gold nanorods (GNRs) are the "gold standard" for PTT due to their unique surface plasmon resonance (SPR) properties. However, clinical translation has been hindered by three primary challenges: the toxicity of surfactants like CTAB used in synthesis, rapid clearance by the immune system, and the difficulty of achieving precise tumor accumulation.
Advancements in Synthesis and Functionalization
Recent research has focused on evolving GNR production from classic seed-mediated growth to more efficient "seedless" and "one-pot" methods. These newer techniques often utilize "greener" reducing agents—such as resveratrol or hydroquinone—to control particle size and shape while minimizing toxic byproducts.
Surface functionalization is critical for transforming GNRs into viable therapeutic agents. By coating the gold core with substances like polyethylene glycol (PEG), proteins (e.g., albumin), or even cell membranes (e.g., from macrophages), researchers can create a "stealth" effect, extending circulation time and improving biocompatibility.
Optical Tunability and the Aspect Ratio
The defining feature of GNRs is their "tunability." By adjusting the aspect ratio—the ratio of the rod's length to its width—the longitudinal surface plasmon resonance can be shifted across the near-infrared (NIR) spectrum. This allows GNRs to be optimized for wavelengths that penetrate deepest into human tissue, maximizing the efficiency of the photothermal effect.
Innovative Targeting and Synergistic Therapies
Beyond simple injection, researchers are exploring "Trojan Horse" strategies. GNRs can be loaded into carrier cells, such as mesenchymal stem cells, which naturally migrate toward tumor-induced inflammation. Furthermore, GNRs are increasingly used as dual-purpose vehicles, carrying chemotherapy drugs that are released only when triggered by laser-induced heat or the acidic tumor environment. This synergy allows for complete tumor regression in animal models using significantly lower drug doses, thereby reducing systemic side effects.
Future Perspectives and Challenges
Despite significant progress, hurdles remain for clinical adoption. The complexity of multi-functional coatings makes large-scale, consistent manufacturing difficult. Additionally, the "protein corona"—a layer of blood proteins that coats nanoparticles in vivo—can mask targeting ligands, leading to discrepancies between lab results and clinical performance. Future research must address the long-term clearance of gold from the body, potentially through the development of biodegradable or ultrasmall GNRs that can be excreted via the kidneys.
Summary updated